Synthesis of Neurologically Active Small Molecules
神经活性小分子的合成
基本信息
- 批准号:9929899
- 负责人:
- 金额:$ 9.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-01 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseArchitectureAreaAttenuatedBiologicalCaspaseCause of DeathCell DeathChemicalsCombinatorial SynthesisCommon CoreComplexCore AssemblyCouplingDevelopmentDisease modelEconomicsElderlyElementsEtiologyEvaluationFamilyFuransGlutamatesGoalsLaboratoriesLibrariesLong-Term PotentiationMalignant NeoplasmsMediatingMemoryMethodologyMethodsModificationMolecularNatural ProductsNerve DegenerationNeurodegenerative DisordersNeurologicParkinson DiseasePathway interactionsPharmacologyPhosphotransferasesProcessProductionPropertyProteinsReactive Oxygen SpeciesReportingResearchRoleRouteStructureStructure-Activity RelationshipTestingTherapeuticTherapeutic InterventionTropomyosinUnited Statesaging populationanalogbasecare costscognitive functiondehydrogenationdisabilitydrug discoveryflexibilityimprovedinhibitor/antagonistmembermouse modelnervous system disorderneuron lossnoveloxidationpreventprotein kinase Rreceptorrhodotoxinscaffoldsmall moleculesocialtherapy development
项目摘要
Project Summary/Abstract
The understanding of normal cognitive function and the development of treatments for
neurodegenerative diseases have been enabled by the study of natural products and their synthetic congeners.
The extensive discoveries made in this realm have been limited primarily to the specific activities of abundantly
available natural products or simple derivatives thereof. The long-term goal of this proposal is to use
fragment-coupling approaches to synthesize varied, stereochemically rich, polycyclic natural product
architectures with the potential to further the understanding of neurodegenerative disorders.
This proposal outlines two convergent approaches for the synthesis of two families of natural
products, the grayanotoxins and the limonoids, both of which have been shown to attenuate neuronal cell
death caused by reactive oxygen species. By departing from conventional strategies that cyclize linear
precursors, this proposal utilizes the convergent and scalable assembly of building blocks into structurally
differentiated scaffolds. In line with conventional approaches, the molecular architectures obtained through
this approach will be subsequently modified through the application of a dehydrogenation methodology
recently reported by our laboratory, as well as by other chemical strategies.
Novel analogs produced by these routes will be evaluated for their ability to alleviate the effects of
reactive oxygen species on neurodegeneration. Through increased understanding of neurodegeneration on a
molecular level, potential avenues for drug discovery and therapeutic intervention will be revealed.
项目摘要/摘要
对正常认知功能的认识及治疗进展
通过对天然产物及其合成同系物的研究,神经退行性疾病成为可能。
在这一领域取得的广泛发现主要局限于丰盛的特定活动
可获得的天然产品或其简单的衍生产品。这项提议的长期目标是使用
片段偶联方法合成多种立体化学丰富的多环天然产物
有可能进一步了解神经退行性疾病的体系结构。
这一建议概述了合成两个天然化合物家族的两种收敛方法。
灰霉毒素和柠檬苦素,这两种物质都被证明可以削弱神经细胞。
由活性氧类引起的死亡。通过背离传统的线性循环策略
作为先驱,该提议利用构建块的聚合和可扩展组装在结构上
差异化的支架。与常规方法一致,通过
随后将通过应用脱氢方法对这一方法进行修改
最近由我们实验室以及其他化学策略报告的。
通过这些路线产生的新的类似物将被评估它们是否能够缓解
活性氧对神经退行性变的影响。通过增加对神经退行性变的了解
分子水平,潜在的药物发现和治疗干预的途径将被揭示。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Timothy Newhouse其他文献
Timothy Newhouse的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Timothy Newhouse', 18)}}的其他基金
Synthesis of Neurologically Active Small Molecules
神经活性小分子的合成
- 批准号:
10174940 - 财政年份:2017
- 资助金额:
$ 9.99万 - 项目类别:
Synthesis of Neurologically Active Small Molecules
神经活性小分子的合成
- 批准号:
10387570 - 财政年份:2017
- 资助金额:
$ 9.99万 - 项目类别:
Synthesis of Neurologically Active Small Molecules
神经活性小分子的合成
- 批准号:
10661097 - 财政年份:2017
- 资助金额:
$ 9.99万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 9.99万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 9.99万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 9.99万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 9.99万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 9.99万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 9.99万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 9.99万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 9.99万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 9.99万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 9.99万 - 项目类别: